S054 What's New in Dermatopathology
DESCRIPTION
This symposium provides information regarding advances in key areas of dermatopathology. Cutaneous neoplasia, inflammatory skin disease, molecular techniques, computer assisted diagnosis/artificial intelligence, translational research, and cutaneous infections will be covered. New this year will be an update on reimbursement and payer-related issues. Attendees will leave the session with updated knowledge in dermatopathology.
LEARNING OBJECTIVES
Describe new advances in cutaneous neoplasia, including melanocytic tumors and adnexal neoplasms
Discuss recent developments in diagnosing inflammatory skin disease, immune bullous disorders, and cutaneous drug reactions
Describe recent developments in reimbursement and payer-related issues in the field of dermatopathology
DIRECTOR
Anisha Patel, MD, FAAD
UT MD Anderson Cancer Center
SPEAKERS
Shruti Agrawal, MD, FAAD
Ryan Walter Hick, MD, FAAD
ProPath Dermatopathology
Angela Juan Jiang, MD, FAAD
Oregon Health & Science University
Kiran Motaparthi, MD, FAAD
Jeffrey P. North, MD, FAAD
Iwei Yeh, MD, PhD, FAAD
University of California, San Francisco
DISCLOSURES
Shruti Agrawal, MD, FAAD
No financial relationships exist with ineligible companies.
Ryan Walter Hick, MD, FAAD
PP Capital – Stockholder(No Compensation Received); Sonic Healthcare – Stockholder(No Compensation Received); Stingray Therapeutics – Stockholder(No Compensation Received);
Angela Juan Jiang, MD, FAAD
No financial relationships exist with ineligible companies.
Kiran Motaparthi, MD, FAAD
No financial relationships exist with ineligible companies.
Jeffrey P. North, MD, FAAD
Johnson & Johnson Pharmaceutical Research & Development – Consultant (1099 relationship)(Fees);
Anisha Patel, MD, FAAD
Astellas Pharma US, Inc – Consultant (1099 relationship)(Fees); Asymmetric Therapeutics, LLC – Consultant (1099 relationship)(Fees); Deciphera Pharmaceuticals, Inc. – Consultant (1099 relationship)(Fees); EMD Serono – Advisory Board(Fees); Erasca – Consultant (1099 relationship)(Fees); FBIO Acquisition Corp LXI – Consultant (1099 relationship)(Stock); Hoth Therapeutics – Investigator(Grants/Research Funding); IDEOlogy Health – Consultant (1099 relationship)(Fees); Janssen Scientific Affairs, LLC – Consultant (1099 relationship)(Fees); Lutris – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Revolution Medicines – Advisory Board(Fees); Roche Pharma – Consultant (1099 relationship)(Fees); SynOx Therapeutics – Consultant (1099 relationship)(Fees); UpToDate, Inc – Other(Patent royalties or other compensation for Intellectual Property Rights);
Iwei Yeh, MD, PhD, FAAD
Pfizer Inc. – Investigator(Grants/Research Funding); Regeneron Pharmaceuticals Inc – Advisory Board(Honoraria);